OIS Podcast | Ophthalmology's leading Podcast

Clearside Biomedical Finds the Public Markets Despite Diminished Interest in Sector

OIS

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 21:41
Clearside CEO Dan White says the days when ophthalmology IPO candidates could do no wrong are over. Still, the company staged a successful IPO to help further development of its SCS microinjector technology.